Sfoglia per Autore
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: A possible role in glucocorticoid deficiency
2015-01-01 Spadaro, L.; Noto, D.; Privitera, G.; Tomaselli, T.; Fede, G.; Scicali, R.; Piro, S.; Fayer, F.; Altieri, I.; Averna, M.; Purrello, F.
Erratum: FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease (Analytical and Bioanalytical Chemistry DOI: 10.1007/s00216-015-9229-6)
2016-01-01 Francesca Di Gaudio; Sergio Indelicato; Roberto Monastero; Grazia Ida Altieri; Francesca Fayer; Ornella Palesano; Manuela Fontana; Angelo B. Cefalu; Massimiliano Greco; David Bongiorno; Serena Indelicato; Angela Aronica; Davide Noto; Maurizio Averna;
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease
2016-01-01 Di Gaudio, F.; Indelicato, S.; Monastero, R.; Altieri, G.; Fayer, F.; Palesano, O.; Fontana, M.; Cefalù, A.; Greco, M.; Bongiorno, D.; Indelicato, S.; Aronica, A.; Noto, D.; Averna, M.
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing
2017-01-01 Cefalu', A; Spina, R; Noto, D; Ingrassia, V.; Valenti, V; Giammanco, A; Fayer, F; Misiano, G; Cocorullo, G; Scrimali, C; Palesano, O; Altieri, G; Ganci, A; Barbagallo, C; Averna, M
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY
2019-01-01 Scrimali, C; Spina, R; Ingrassia, V; Cefalu, AB; Brucato, F; Misiano, G; Valenti, V; Noto, D; Altieri, GI; Fayer, F; Giammanco, A; Barbagallo, C; Averna, M
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS
2020-01-01 Giammanco, Antonina; Scrimali, C; Spina, R; Ingrassia, V; Brucato, F; Valenti, V; Cefalu, AB; Misiano, G; Altieri, GI; Noto, D; Barbagallo, CM; Ganci, A; Fayer, F; Averna, M
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES"
2020-01-01 Brucato, F; Martinelli, N; Spina, R; Busti, F; Ingrassia, V; Scrimali, C; Altieri, GI; Noto, D; Misiano, G; Giammanco, A; Barbagallo, CM; Fayer, F; Cefalu, AB; Olivieri, O; Girelli, D; Averna, M
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study
2020-01-01 Valenti V; Noto D; Giammanco A; Fayer F; Spina R; Altieri GI; Ingrassia V; Scrimali C; Barbagallo CM; Brucato F; Misiano G; Cefalu AB; Averna M.
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY
2020-01-01 Scrimali, C; Spina, R; Ingrassia, V; Brucato, F; Altieri, GI; Noto, D; Valenti, V; Misiano, G; Giammanco, A; Fayer, F; Barbagallo, CM; Ganci, A; Cefalu, AB; Averna, M
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography
2021-01-01 Noto D.; Cefalu A.B.; Martinelli N.; Giammanco A.; Spina R.; Barbagallo C.M.; Caruso M.; Novo S.; Sarullo F.; Pernice V.; Brucato F.; Ingrassia V.; Fayer F.; Altieri G.I.; Scrimali C.; Misiano G.; Olivieri O.; Girelli D.; Averna M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile